FDA approves Novartis drug for rare blood disorder
The FDA has approved Novartis’ pill iptacopan for adults with paroxysmal nocturnal hemoglobinuria, or PNH, a rare disorder where the red blood cells break up …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.